|
C16ORF80 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.755500E-03 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.697400E-03 |
| Normal-vs-AfricanAmerican |
1.558220E-02 |
| Normal-vs-Asian |
1.085570E-01 |
| Caucasian-vs-AfricanAmerican |
9.966200E-01 |
| Caucasian-vs-Asian |
5.668200E-01 |
| AfricanAmerican-vs-Asian |
6.300200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.355600E-03 |
| Normal-vs-Female |
1.221690E-02 |
| Male-vs-Female |
2.105200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.443800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.105990E-02 |
| Normal-vs-Age(61-80Yrs) |
2.571700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.087500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.696400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.975400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.473200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.386800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.824400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
1.398390E-02 |
| Normal-vs-Pheochromocytoma |
6.179700E-03 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.864500E-02 |
| Paraganglioma-vs-Pheochromocytoma |
5.592400E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
5.787600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.385800E-01 |
|
|
